DMD
Clinical trials for DMD explained in plain language.
Never miss a new study
Get alerted when new DMD trials appear
Sign up with your email to follow new studies for DMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a blood flow drug and exercise boost muscle strength in duchenne?
Disease control Recruiting nowThis study looks at two add-on treatments for Duchenne muscular dystrophy (DMD): a drug called tadalafil that improves blood flow, and aerobic exercise training. The goal is to see if these can improve muscle function and delay disease progression. About 50 ambulatory children wi…
Matched conditions: DMD
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated May 26, 2026 03:45 UTC
-
New pill could help boys with duchenne MD move stronger
Disease control Recruiting nowThis study tests an oral drug called SAT-3247 in 51 boys aged 7 to 10 with Duchenne muscular dystrophy (DMD). The goal is to see if it can improve muscle strength and function over 12 weeks. Participants will take the drug or a placebo on weekdays, and all will continue their usu…
Matched conditions: DMD
Phase: PHASE2 • Sponsor: Satellos Bioscience, Inc. • Aim: Disease control
Last updated May 26, 2026 03:44 UTC
-
Gene therapy hope for boys with duchenne muscular dystrophy
Disease control Recruiting nowThis early-stage study tests a new gene therapy called BBM-D101 in 9 boys aged 4 to 8 with Duchenne muscular dystrophy. The goal is to see if it is safe and can help restore a missing muscle protein. Participants receive one infusion and are monitored for side effects and changes…
Matched conditions: DMD
Phase: PHASE1, PHASE2 • Sponsor: Belief BioMed (Beijing) Co., Ltd • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
New drug aims to restore muscle protein in boys with DMD
Disease control Recruiting nowThis study tests a weekly intravenous drug, NS-089/NCNP-02, in 20 boys aged 4 to 14 with Duchenne muscular dystrophy (DMD) who have a specific genetic mutation. The goal is to help their bodies produce a missing muscle protein, dystrophin, to slow muscle damage. Participants must…
Matched conditions: DMD
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
Swiss launch major registry to track rare muscle diseases
Knowledge-focused Recruiting nowThis study is a registry that collects health information from people in Switzerland who have neuromuscular disorders like SMA, Duchenne, and Becker muscular dystrophy. The goal is to track their health over time to help improve treatments and care. Up to 2000 children and adults…
Matched conditions: DMD
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated May 26, 2026 03:38 UTC